/CALZF
CALZF Stock - PolyNovo Limited
Healthcare|Medical - DevicesOTC
$0.74+0.00%
+$0.00 (+0.00%) • Dec 19
51
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.24
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.53
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.82
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CALZF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.74 – $0.75
TARGET (TP)$0.86
STOP LOSS$0.69
RISK/REWARD1:2.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.69
52W High$1.82
52W Low$0.61
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $127.24M | $103.19M | $65.24M | $41.44M | $29.16M |
| Gross Profit | $122.05M | $97.71M | $60.81M | $39.24M | $27.60M |
| Gross Margin | 95.9% | 94.7% | 93.2% | 94.7% | 94.7% |
| Operating Income | $4.48M | $1.16M | $-6,185,000 | $-257,000 | $-3,147,000 |
| Net Income | $13.21M | $5.26M | $-4,925,000 | $-1,193,000 | $-4,605,000 |
| Net Margin | 10.4% | 5.1% | -7.5% | -2.9% | -15.8% |
| EPS | $0.02 | $0.01 | $-0.01 | $-0.00 | $-0.01 |
Company Overview
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CALZFBeat Rate
40%
Last 10 quarters
Avg Surprise
-77.0%
EPS vs Estimate
Beats / Misses
4/6
Last 12 quarters
Latest EPS
$0.00
Q3 2025
EPS Surprise History
Q4 21
+161.0%
$0.00vs$-0.00
Q2 22
-323.2%
$-0.00vs$-0.00
Q4 22
-389.0%
$-0.00vs$0.00
Q2 23
+84.1%
$-0.00vs$-0.01
Q2 24
No data
Q3 24
-26.7%
$0.00vs$0.00
Q1 25
+6.1%
$0.00vs$0.00
Q3 25
+1.8%
$0.00vs$0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 23, 2026 | — | — | — | — |
Q3 2025 | Aug 25, 2025 | $0.00 | $0.00 | +1.8% | ✓ BEAT |
Q1 2025 | Feb 25, 2025 | $0.00 | $0.00 | +6.1% | ✓ BEAT |
Q3 2024 | Aug 22, 2024 | $0.00 | $0.00 | -26.7% | ✗ MISS |
Q2 2024 | May 8, 2024 | — | $0.00 | — | — |
Q2 2023 | Jun 30, 2023 | $-0.01 | $-0.00 | +84.1% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | $0.00 | $-0.00 | -389.0% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $-0.00 | $-0.00 | -323.2% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | $-0.00 | $0.00 | +161.0% | ✓ BEAT |
Q2 2021 | Jun 30, 2021 | $-0.00 | $-0.00 | -61.3% | ✗ MISS |
Q4 2020 | Dec 31, 2020 | $-0.00 | $-0.00 | -32.7% | ✗ MISS |
Q2 2020 | Jun 30, 2020 | $0.00 | $-0.00 | -189.9% | ✗ MISS |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.00 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.00 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.00 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.00 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CALZF
What is CALZF's current stock price?
PolyNovo Limited (CALZF) is currently trading at $0.74 per share. The stock has moved +0.00% today.
What is the analyst price target for CALZF?
No analyst price targets are currently available for this stock.
What sector is PolyNovo Limited in?
PolyNovo Limited operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is CALZF's market cap?
PolyNovo Limited has a market capitalization of $0.51 billion, making it a small-cap company.
Does CALZF pay dividends?
No, PolyNovo Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVNBF
Avon Technologies Plc
$23.40
Mkt Cap: $0.7B
BJTRF
Beijing Tong Ren Tang Chinese Medicine Company Limited
$0.65
Mkt Cap: $0.5B
BOIRF
Boiron S.A.
$30.00
Mkt Cap: $0.5B
CLVSF
CellaVision AB (publ)
$16.83
Mkt Cap: $0.4B
FDMDF
4DMedical Limited
$2.35
Mkt Cap: $1.2B
JNDOF
JINS HOLDINGS Inc.
$22.75
Mkt Cap: $0.5B
LBLTF
Lattice Biologics Ltd.
$0.00
Mkt Cap: $0.0B
SOLTF
Nxera Pharma Co., Ltd.
$5.34
Mkt Cap: $0.5B
SWDCF
Swedencare AB (publ)
$3.87
Mkt Cap: $0.6B
XVIPF
Xvivo Perfusion AB (publ)
$19.40
Mkt Cap: $0.6B
Explore stocks similar to CALZF for comparison